Hearing on "Protecting American Health Security: Oversight of the Shortcomings in the FDA's Foreign Drug Inspection Program"
Date:
Location:
2322 Rayburn House Office Building
The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce held a hearing on Tuesday, February 6, 2024, at 10:30 a.m. in 2322 Rayburn House Office Building. The hearing was entitled, “Protecting American Health Security: Oversight of Shortcomings in the FDA’s Foreign Drug Inspection Program.”
Key Documents
Opening Statement from Ranking Member Pallone as prepared for delivery
Opening Statement from Subcommittee on Oversight and Investigations Ranking Member Castor as prepared for delivery
Livestream
Witnesses
Mary Denigan-Macauley, Ph.D.
Director of Public Health
U.S. Government Accountability Office
John W.M. Claud, J.D
Counsel
Hyman, Phelps & McNamara
Dinesh S. Thakur
Public Health Activist
Thakur Family Foundation, Inc.
Subcommittees
Issues:Health